Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial
NCT00046644 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2014-04-17
Summary
To elucidate the mechanisms underlying inter-patient variation in response to montelukast, a drug for asthma.
Conditions
- Asthma
- Lung Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Nemours Children's Clinic
lead OTHER
Principal Investigators
-
John Lima · Nemours Children's Clinic
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2005-05-31
- Completion
- 2005-05-31
More Related Trials
-
Montelukast With Status Asthmaticus, Ages 6-18
NCT00494572 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)
NCT00943683 ·Status: COMPLETED ·Phase: NA
-
Effect of Montelukast in Asthma in Children
NCT01266772 ·Status: UNKNOWN ·Phase: PHASE3
-
Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
NCT00446056 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
NCT00140946 ·Status: COMPLETED ·Phase: PHASE4
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma
NCT00543686 ·Status: COMPLETED ·Phase: PHASE2
-
Montelukast With Status Asthmaticus, Ages 2-5
NCT00491790 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)
NCT00666679 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Montelukast in Asthma
NCT01011452 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
NCT00540839 ·Status: WITHDRAWN ·Phase: PHASE3
-
Wheeze and Intermittent Treatment
NCT01142505 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis
NCT01230437 ·Status: UNKNOWN
-
Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
NCT00968201 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma in the Elderly: The Effect of Montelukast
NCT02635334 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children
NCT01458418 ·Status: TERMINATED ·Phase: NA
-
Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness
NCT00913328 ·Status: COMPLETED ·Phase: PHASE4
-
Montelukast Back to School Asthma Study (0476-340)
NCT00461032 ·Status: COMPLETED ·Phase: PHASE3
-
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
NCT01759472 ·Status: UNKNOWN
-
Predicting the Response to Montelukast by Genetic Variation in Asthmatics
NCT00116324 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in Modulating Exacerbations of Asthma in Children
NCT00196547 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
NCT00213252 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
NCT00636207 ·Status: COMPLETED ·Phase: PHASE1
-
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
NCT00284856 ·Status: COMPLETED ·Phase: PHASE3